The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer

Journal of the American College of Surgeons

Volumn 199, Issue 3, 2004, Pages 479-492

  Pawlik, Timothy M ^a   Buchholz, Thomas A ^a   Kuerer, Henry M ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

accelerated partial breast irradiation; APBI; BCS; BCT; breast conserving surgery; breast conserving therapy; EBRT; EIC; extensive intraductal component; external beam radiation therapy; HDR; high dose rate; IMRT; intensity modulated radiation therapy; IORT

Indexed keywords

ANTIBIOTIC AGENT; CONTRAST MEDIUM; DOXORUBICIN;

ACUTE TOXICITY; BEAM THERAPY; BRACHYTHERAPY; BREAST CANCER; BREAST FIBROSIS; CANCER RADIOTHERAPY; CELLULITIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DESQUAMATION; EDEMA; ERYTHEMA; FAT NECROSIS; HEMATOMA; HUMAN; IATROGENIC DISEASE; INSURANCE; PAIN; PARTIAL MASTECTOMY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; TELANGIECTASIA;

BRACHYTHERAPY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 4344587156     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.04.019     Document Type: Review

References (100)

1. Gage I., Recht A., Gelman R., et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 33:1995;245-251
2. Veronesi U., Salvadori B., Luini A., et al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg. 211:1990;250-259
3. Kurtz J.M., Spitalier J.M., Amalric R., et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 18:1990;87-93
4. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 333:1995;1456-1461
5. Sarrazin D., Le M.G., Arriagada R., et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 14:1989;177-184
6. van Dongen J.A., Bartelink H., Fentiman I.S., et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;15-18
7. Fourquet A., Campana F., Zafrani B., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer a 25-year follow-up. Int J Radiat Oncol Biol Phys. 17:1989;719-725
8. Fowble B., Solin L.J., Schultz D.J., et al. Breast recurrence following conservative surgery and radiation patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 19:1990;833-842
9. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 332:1995;907-911
10. Haffty B.G., Goldberg N.B., Fischer D., et al. Conservative surgery and radiation therapy in breast carcinoma local recurrence and prognostic implications. Int J Radiat Oncol Biol Phys. 17:1989;727-732
11. Stotter A.T., McNeese M.D., Ames F.C., et al. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer. 64:1989;2217-2225
12. Clarke D.H., Edmundson G.K., Martinez A., et al. The clinical advantages of I-125 seeds as a substitute for Ir-192 seeds in temporary plastic tube implants. Int J Radiat Oncol Biol Phys. 17:1989;859-863
13. Vicini F.A., Recht A., Abner A., et al. Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monogr. 1992;33-39
14. Abner A.L., Recht A., Eberlein T., et al. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 11:1993;44-48
15. Fisher B., Bauer M., Margolese R., et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 312:1985;665-673
16. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 347:2002;1233-1241
17. Hillner B.E., Penberthy L., Desch C.E., et al. Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat. 40:1996;75-86
18. Farrow D.C., Hunt W.C., Samet J.M. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 326:1992;1097-1101
19. Hill D.J., White V.M., Giles G.G., et al. Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust. 161:1994;110-111. 114, 118 passim
20. Lazovich D.A., White E., Thomas D.B., Moe R.E. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA. 266:1991;3433-3438
21. Goel V., Olivotto I., Hislop T.G., et al. Patterns of initial management of node-negative breast cancer in two Canadian provinces. British Columbia/Ontario Working Group. CMAJ. 156:1997;25-35
22. Mandelblatt J.S., Hadley J., Kerner J.F., et al. Patterns of breast carcinoma treatment in older women patient preference and clinical and physical influences. Cancer. 89:2000;561-573
23. Morrow M., White J., Moughan J., et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 19:2001;2254-2262
24. Young W.W., Marks S.M., Kohler S.A., Hsu A.Y. Dissemination of clinical results. Mastectomy versus lumpectomy and radiation therapy. Med Care. 34:1996;1003-1017
25. Osteen R.T., Cady B., Friedman M., et al. Patterns of care for younger women with breast cancer. J Natl Cancer Inst Monogr. 1994;43-46
26. Osteen R.T., Cady B., Chmiel J.S., et al. 1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg. 178:1994;213-219
27. Guadagnoli E., Shapiro C.L., Weeks J.C., et al. The quality of care for treatment of early stage breast carcinoma is it consistent with national guidelines? Cancer. 83:1998;302-309
28. Hillner B.E., McDonald M.K., Penberthy L., et al. Measuring standards of care for early breast cancer in an insured population. J Clin Oncol. 15:1997;1401-1408
29. Hebert-Croteau N., Brisson J., Latreille J., et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer. 85:1999;1104-1113
30. Hebert-Croteau N., Brisson J., Latreille J., et al. Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ. 161:1999;951-955
31. Ballard-Barbash R., Potosky A.L., Harlan L.C., et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 88:1996;716-726
32. Riley G.F., Potosky A.L., Klabunde C.N., et al. Stage at diagnosis and treatment patterns among older women with breast cancer an HMO and fee-for-service comparison. JAMA. 281:1999;720-726
33. Potosky A.L., Merrill R.M., Riley G.F., et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst. 89:1997;1683-1691
34. Holland R., Veling S.H., Mravunac M., Hendriks J.H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 56:1985;979-990
35. Vaidya J.S., Vyas J.J., Chinoy R.F., et al. Multicentricity of breast cancer whole-organ analysis and clinical implications. Br J Cancer. 74:1996;820-824
36. Morimoto T., Okazaki K., Komaki K., et al. Cancerous residue in breast-conserving surgery. J Surg Oncol. 52:1993;71-76
37. Vicini F.A., Baglan K.L., Kestin L.L., et al. Accelerated treatment of breast cancer. J Clin Oncol. 19:2001;1993-2001
38. Boyages J., Recht A., Connolly J.L., et al. Early breast cancer predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol. 19:1990;29-41
39. Clark R.M., McCulloch P.B., Levine M.N., et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 84:1992;683-689
40. Liljegren G., Holmberg L., Bergh J., et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer a randomized trial. J Clin Oncol. 17:1999;2326-2333
41. Touboul E., Buffat L., Belkacemi Y., et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 43:1999;25-38
42. Smith T.E., Lee D., Turner B.C., et al. True recurrence vs. new primary ipsilateral breast tumor relapse an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 48:2000;1281-1289
43. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma long-term results of a randomized trial. Ann Oncol. 12:2001;997-1003
44. Huang E., Buchholz T.A., Meric F., et al. Classifying local disease recurrences after breast conservation therapy based on location and histology new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 95:2002;2059-2067
45. Fortin A., Larochelle M., Laverdiere J., et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 17:1999;101-109
46. Holland R., Connolly J.L., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 8:1990;113-118
47. Gage I., Schnitt S.J., Nixon A.J., et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 78:1996;1921-1928
48. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 18:2000;1668-1675
49. White J.R., Wilson J.F. Brachytherapy and breast cancer. Semin Surg Oncol. 13:1997;190-195
50. Keynes G. The treatment of primary carcinoma of the breast with radium. Acta Radiol. 10:1929;393-402
51. Mansfield C.M., Komarnicky L.T., Schwartz G.F., et al. Perioperative implantation of iridium-192 as the boost technique for stage I and II breast cancer results of a 10-year study of 655 patients. Radiology. 192:1994;33-36
52. Frazier R.C., Kestin L.L., Kini V., et al. Impact of boost technique on outcome in early-stage breast cancer patients treated with breast-conserving therapy. Am J Clin Oncol. 24:2001;26-32
53. de la Rochefordiere A., Abner A.L., Silver B., et al. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys. 23:1992;925-931
54. Hennequin C., Durdux C., Espie M., et al. High-dose-rate brachytherapy for early breast cancer an ambulatory technique. Int J Radiat Oncol Biol Phys. 45:1999;85-90
55. Moreno F., Guedea F., Lopez Y., et al. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer. Int J Radiat Oncol Biol Phys. 48:2000;757-765
56. Shank B., Moughan J., Owen J., et al. The 1993-94 patterns of care process survey for breast irradiation after breast-conserving surgery-comparison with the 1992 standard for breast conservation treatment. The Patterns of Care Study, American College of Radiology. Int J Radiat Oncol Biol Phys. 48:2000;1291-1299
57. Kuerer H.M., Julian T.B., Strom E.A., et al. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg. 239:2004;338-351
58. Perera F., Engel J., Holliday R., et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer a pilot study. J Surg Oncol. 65:1997;263-267. discussion 267-268
59. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 180:2000;299-304
60. Fentiman I.S., Poole C., Tong D., et al. Iridium implant treatment without external radiotherapy for operable breast cancer a pilot study. Eur J Cancer. 27:1991;447-450
61. Clarke D.H., Vicini F., Jacobs H. High dose rate brachytherapy for breast cancer. Nag S. High dose rate brachytherapy. 1994;321-329 Futura Publishing, Armonk, New York
62. Martinez A., Chen P.Y., Gustafson G. Irradiation of the tumor bed alone after lumpectomy with high dose rate brachytherapy. 1997;. Proceedings of the 19th Annual Meeting of the American Brachytherapy Society
63. Fentiman I.S., Poole C., Tong D., et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 32A:1996;608-611
64. Kuske R.R., Bolton J.S., McKinnon W.M.P. 5-year results of a prospective phase II trial of wide-volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer (Abstr.). Int J Radiat Oncol Biol Phys. 42:1998;181
65. Perera F., Yu E., Engel J., et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys. 57:2003;1239-1246
66. Jewell W.R., Krishnan L., Reddy E.K., et al. Intraoperative implantation radiation therapy plus lumpectomy for carcinoma of the breast. Arch Surg. 122:1987;687-690
67. Vicini F.A., Kestin L., Chen P., et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 95:2003;1205-1210
68. Wazer D.E., Lowther D., Boyle T., et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 50:2001;107-111
69. Wazer D.E., Berle L., Graham R., et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 53:2002;889-897
70. Radiation Oncology Study Group. Available at http://www.rtog.org. Accessed June 2, 2004
71. Polgar C., Sulyok Z., Fodor J., et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 80:2002;121-128. discussion 129
72. Olivotto I.A., Rose M.A., Osteen R.T., et al. Late cosmetic outcome after conservative surgery and radiotherapy analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys. 17:1989;747-753
73. Ray G.R., Fish V.J. Biopsy and definitive radiation therapy in stage I and II adenocarcinoma of the female breast analysis of cosmesis and the role of electron beam supplementation. Int J Radiat Oncol Biol Phys. 9:1983;813-818
74. Fourquet A., Campana F., Mosseri V., et al. Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone final results of a randomized trial. Radiother Oncol. 34:1995;114-120
75. Perez C.A., Taylor M.E., Halverson K., et al. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 34:1996;995-1007
76. Mansfield C.M., Komarnicky L.T., Schwartz G.F., et al. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer. 75:1995;2328-2336
77. Touboul E., Belkacemi Y., Lefranc J.P., et al. Early breast cancer influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol. 34:1995;105-113
78. Arthur D.W., Koo D., Zwicker R.D., et al. Partial breast brachytherapy after lumpectomy low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 56:2003;681-689
79. Edmundson G.K., Vicini F.A., Chen P.Y., et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 52:2002;1132-1139
80. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 55:2003;289-293
81. Hwang E.S., Samli B., Tran K.N., et al. Volume of resection in patients treated with breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 5:1998;757-763
82. Pawlik T.M., Perry A., Strom E.A., et al. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer. 100:2004;490-498
83. Kuerer H.M., Chung M., Giovanna G., et al. The case for accelerated partial-breast irradiation for breast cancer. Contemp Surg. 59:2003;508-516
84. Intra M., Gatti G., Luini A., et al. Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg. 137:2002;737-740
85. Gatzemeier W., Orecchia R., Gatti G., et al. [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma - a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand]. Strahlenther Onkol. 177:2001;330-337
86. Veronesi U., Orecchia R., Luini A., et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 37:2001;2178-2183
87. Veronesi U., Gatti G., Luini A., et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg. 138:2003;1253-1256
88. Vaidya J.S., Baum M., Tobias J.S., et al. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol. 28:2002;447-454
89. Formenti S.C., Rosenstein B., Skinner K.A., Jozsef G. T1 stage breast cancer adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients - pilot feasibility study. Radiology. 222:2002;171-178
90. Vicini F.A., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 57:2003;1247-1253
91. Melian E., Mageras G.S., Fuks Z., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys. 38:1997;73-81
92. Ross C.S., Hussey D.H., Pennington E.C., et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. Int J Radiat Oncol Biol Phys. 18:1990;671-677
93. Frazier R.C., Vicini F., Sharpe M.B. The impact of respiration on whole breast radiotherapy a dosimetric analysis using active breathing control (Abstr.). Int J Radiat Oncol Biol Phys. 48:2000;200
94. Baglan K.L., Sharpe M.B., Jaffray D., et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 55:2003;302-311
95. Vicini F.A., Sharpe M., Kestin L., et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 54:2002;1336-1344
96. Strom E.A. Breast IMRT new tools leading to new vision. Int J Radiat Oncol Biol Phys. 54:2002;1297-1298
97. Krueger E.A., Fraass B.A., Pierce L.J. Clinical aspects of intensity-modulated radiotherapy in the treatment of breast cancer. Semin Radiat Oncol. 12:2002;250-259
98. Consensus statement for accelerated partial breast irradiation. 2004;. Available at http://www.breastsurgeons.org/officialstmts/officialstmt3.shtml. Accessed June 2
99. Krishnan L., Jewell W.R., Tawfik O.W., Krishnan E.C. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 7:2001;91-96
100. Polgar C., Fodor J., Major T., et al. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects. Strahlenther Onkol. 178:2002;597-606